CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.

Details

Language :

English

ISSN :

19420862

Volume :

8

Issue :

3

Database :

Complementary Index

Journal :

mAbs

Publication Type :

Academic Journal

Accession number :

114081701

Full Text :

https://doi.org/10.1080/19420862.2015.1119352